1-deoxynojirimycin has been researched along with Heart Disease, Ischemic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, M; Chen, XH; Fujiwara, H; Hashimoto, K; Lu, C; Minatoguchi, S; Takemura, G; Uno, Y; Wang, N | 1 |
| Depre, C; Hue, L | 1 |
| Arai, M; Chen, XH; Fujiwara, H; Fujiwara, T; Hashimoto, K; Minatoguchi, S; Nishida, Y; Takemura, G; Uno, Y; Wang, N | 1 |
3 other study(ies) available for 1-deoxynojirimycin and Heart Disease, Ischemic
| Article | Year |
|---|---|
The anti-diabetic drug miglitol is protective against anginal ischaemia through a mechanism independent of regional myocardial blood flow in the dog.
Topics: 1-Deoxynojirimycin; Angina Pectoris; Animals; Blood Glucose; Blood Pressure; Coronary Circulation; Dogs; Glucosamine; Heart Rate; Hypoglycemic Agents; Imino Pyranoses; Lactates; Male; Myocardial Ischemia; Myocardium | 2005 |
Inhibition of glycogenolysis by a glucose analogue in the working rat heart.
Topics: 1-Deoxynojirimycin; Animals; Coronary Circulation; Depression, Chemical; Enzyme Inhibitors; Glucosamine; Glucose; Glycogen; Glycogen Debranching Enzyme System; Heart; Insulin; Lactates; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Perfusion; Rats; Rats, Wistar | 1997 |
N-methyl-1-deoxynojirimycin (MOR-14), an alpha-glucosidase inhibitor, markedly improves postischemic left ventricular dysfunction.
Topics: 1-Deoxynojirimycin; Adenosine Triphosphate; Animals; Blood Flow Velocity; Disease Models, Animal; Enzyme Inhibitors; Glycogen; Glycoside Hydrolase Inhibitors; Heart; Lactic Acid; Male; Myocardial Ischemia; Myocardial Reperfusion; Rats; Rats, Sprague-Dawley; Time Factors; Ventricular Dysfunction, Left | 2000 |